At what enterprise value was NOVETUDE SANTE acquired in 2020?

During the acquisition of NOVETUDE SANTE by CHARTERHOUSE in 2020, the company was valued at an estimated revenue multiple of 5x - 12x. The transaction's Enterprise Value is estimated to be in the range of 300M - 700M EUR. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Retail & Consumer industry currently tracks an average EBITDA multiple of 11.0x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of NOVETUDE SANTE when it was acquired by CHARTERHOUSE?

The estimated EV/EBITDA multiple for NOVETUDE SANTE is in the range of 10x - 18x. For comparison, the Retail & Consumer sector currently shows an average EBITDA multiple of 11.0x. Join our community for free to access full valuation data and industry trends.

When was NOVETUDE SANTE acquired by CHARTERHOUSE?

NOVETUDE SANTE was acquired by CHARTERHOUSE in 2020.

What was the revenue of NOVETUDE SANTE at the time of the deal?

The revenue of NOVETUDE SANTE at the time of the deal is estimated to be in the range of 25M - 50M EUR. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of NOVETUDE SANTE during the acquisition?

NOVETUDE SANTE's EBITDA is estimated to be in the range of 10M - 30M EUR. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the NOVETUDE SANTE acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the NOVETUDE SANTE deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.cfnews.net/L-actualite/LBO/Operations/LBO/Novetude-Sante-instruit-son-premier-LBO-346717

← DATABASE

Home Database Retail & ConsumerNOVETUDE SANTE

11/2020

NOVETUDE SANTE acquired by CHARTERHOUSE

FRANCE Education / Education Providers EV 300M - 700M EUR

Context

Charterhouse Capital Partners, the British private equity firm, has acquired a majority stake in Novetude Santé, a French higher education group specialized in health and well-being. The transaction marks a new partnership between two parties with a long-standing history, as Charterhouse was previously a shareholder in Elior between 2006 and 2014.

NOVETUDE SANTE, which reported an EBITDA margin of LOGIN in 2019, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Retail & Consumer sector (11.0x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Retail & Consumer market trends

Target

Novétude Santé is a French higher education and professional training group specializing in healthcare and paramedical professions. Founded in 2010, the group offers a comprehensive range of initial and continuing education programs tailored to healthcare professionals and students aspiring to join these fields. Its portfolio spans disciplines such as osteopathy, pharmacy, medicine, dental care, and other allied health specialties. Over the years, Novétude Santé has expanded its network of institutions and programs through a combination of organic growth and targeted acquisitions. The group comprises several schools, including the ESO Paris osteopathy school, as well as complementary training organizations, enabling it to support learners throughout their professional journey, from initial training to ongoing professional development.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2019

2018

Other operations with NOVETUDE SANTE

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
Date	Acquirer	Target	Country	Sector	Deal Context
05/2025	PEUGEOT INVEST	NOVETUDE SANTE	FRANCE	Education	Peugeot Invest and Hayfim acquires a majority stake in Novetude Sante from Latour Capital. This secondary LBO values the education group at nearly EUR750 million. Under Charterhouse's ownership, the group significantly expanded through buy-and-build strategies

REFERENCES

Valuation range: EV 300M - 700M EUR

Revenue range: 25M - 50M EUR

EBITDA range: 10M - 30M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of NOVETUDE SANTE by CHARTERHOUSE are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Target: novetude sante

Acquirer: charterhouse